Skip to the page

Data / Drug companies / Olopatadine hydrochloride

Olopatadine hydrochloride: 35 companies and 71 products in the FDA NDC directory

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Olopatadine hydrochloride is listed in the FDA National Drug Code Directory by 35 companies, with 71 products in commercial distribution. 68 of the products (95.8%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are solution; solution/ drops; spray, and the newest product started marketing on November 1, 2026.

The request: Get every company that lists olopatadine hydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
35
Products
71
Generic (ANDA) products
68 (95.8%)
Application numbers
21
Routes
Ophthalmic, Nasal
Brand names
Eye Allergy Itch Relief, Pataday Once Daily Relief, Pataday Twice a Day Relief, Olopatadine HCl, Retaine Allergy, Eye Allergy Itch and Redness Relief
openFDA record search
api.fda.gov

Companies that list olopatadine hydrochloride

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Aurohealth LLC6solutionGeneric drugs (ANDA)July 15, 2020
Alembic Pharmaceuticals Inc.4solution/ dropsGeneric drugs (ANDA)February 18, 2021
Walmart Inc.4solution; solution/ dropsGeneric drugs (ANDA)November 1, 2026
Alcon Laboratories, Inc.3solutionNew drug applications (NDA)September 1, 2020
Amerisource Bergen3solutionGeneric drugs (ANDA)May 1, 2026
Apotex Corp.3solution/ drops; spray, meteredGeneric drugs (ANDA)October 6, 2022
Cardinal Health 110, LLC. DBA Leader3solution/ drops; solutionGeneric drugs (ANDA)January 15, 2026
Walgreen Company3solutionGeneric drugs (ANDA)December 22, 2025
Yyba Corp3solutionGeneric drugs (ANDA)September 10, 2026
A-S Medication Solutions2solutionGeneric drugs (ANDA)July 15, 2020
Alembic Pharmaceuticals Limited2solution/ dropsGeneric drugs (ANDA)February 18, 2021
Bausch & Lomb Incorporated2solutionGeneric drugs (ANDA)January 20, 2025
BluePoint Laboratories2solutionGeneric drugs (ANDA)December 5, 2025
Harris Teeter2solutionGeneric drugs (ANDA)July 15, 2020
Kroger Company2solutionGeneric drugs (ANDA)July 15, 2020
Meijer, Inc.2solutionGeneric drugs (ANDA)July 15, 2020
Retail Business Services, LLC2solutionGeneric drugs (ANDA)May 6, 2021
Rising Pharma Holdings, Inc.2solutionGeneric drugs (ANDA)May 1, 2025
Rite Aid Corporation2solutionGeneric drugs (ANDA)July 15, 2020
Rugby Laboratories2solution/ dropsGeneric drugs (ANDA)January 15, 2026
Target Corporation2solution; solution/ dropsGeneric drugs (ANDA)August 15, 2026
Topco Associates LLC2solutionGeneric drugs (ANDA)July 15, 2020
Allegiant Health1solution/ dropsGeneric drugs (ANDA)May 5, 2025
Allwell Health Inc1solutionGeneric drugs (ANDA)July 15, 2020
Amneal Pharmaceuticals LLC1spray, meteredGeneric drugs (ANDA)February 3, 2020
Bryant Ranch Prepack1sprayGeneric drugs (ANDA)June 14, 2017
Bryant Ranch Prepack1sprayGeneric drugs (ANDA)June 14, 2017
Dr. Reddy's Laboratories Inc.1solution/ dropsGeneric drugs (ANDA)April 15, 2026
Glenmark Therapeutics Inc., USA1solutionGeneric drugs (ANDA)February 28, 2025
Golden State Medical Supply, Inc.1solution/ dropsGeneric drugs (ANDA)December 7, 2015
OCuSOFT LLC1solution/ dropsGeneric drugs (ANDA)July 5, 2024
Padagis Israel Pharmaceuticals Ltd1sprayGeneric drugs (ANDA)June 14, 2017
Somerset Therapeutics, LLC1solution/ dropsGeneric drugs (ANDA)December 20, 2024
Sportpharm LLC1solutionGeneric drugs (ANDA)July 15, 2020
Valu Merchandisers Company1solutionGeneric drugs (ANDA)July 15, 2020

Dosage forms

Dosage formProductsShare
Solution4766.2%
Solution/ drops1926.8%
Spray34.2%
Spray, metered22.8%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)6895.8%
New drug applications (NDA)34.2%

Pharmacologic classes

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.